Trexquant Investment LP Invests $16.66 Million in Tenet Healthcare Co. (NYSE:THC)

Trexquant Investment LP purchased a new stake in Tenet Healthcare Co. (NYSE:THCFree Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 131,965 shares of the company’s stock, valued at approximately $16,658,000. Trexquant Investment LP owned 0.14% of Tenet Healthcare at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. New Wave Wealth Advisors LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter valued at $343,000. Swedbank AB lifted its position in shares of Tenet Healthcare by 100.0% during the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock valued at $5,049,000 after buying an additional 20,000 shares in the last quarter. Signet Financial Management LLC acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $1,526,000. China Universal Asset Management Co. Ltd. acquired a new position in shares of Tenet Healthcare during the fourth quarter valued at approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Tenet Healthcare in the 4th quarter valued at $5,892,000. 95.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. KeyCorp dropped their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Truist Financial cut their price target on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $175.00 target price on shares of Tenet Healthcare in a report on Tuesday, December 17th. TD Cowen initiated coverage on shares of Tenet Healthcare in a research report on Wednesday, February 26th. They issued a “buy” rating and a $175.00 target price on the stock. Finally, Morgan Stanley assumed coverage on Tenet Healthcare in a research note on Wednesday, March 26th. They set an “overweight” rating and a $165.00 price target on the stock. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.41.

View Our Latest Stock Report on Tenet Healthcare

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the transaction, the director now directly owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.93% of the stock is owned by corporate insiders.

Tenet Healthcare Trading Down 0.7 %

Shares of NYSE THC opened at $133.55 on Wednesday. The business has a 50-day moving average price of $132.49 and a two-hundred day moving average price of $141.94. Tenet Healthcare Co. has a one year low of $90.03 and a one year high of $171.20. The firm has a market capitalization of $12.70 billion, a PE ratio of 4.14, a PEG ratio of 1.02 and a beta of 2.06. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. As a group, analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.